NCT01521130View on ClinicalTrials.gov

Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children

PHASE1CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Benign Childhood Epilepsy With Centro-Temporal Spikes
Interventions
DRUG

Levetiracetam

Medication doses are defined on a mg/kg basis. Dosage form, frequency and titration schedule is based on accepted clinical practice.

Trial Locations (1)

45229

Cincinnati Children's Hospital, Cincinnati

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT01521130 - Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children | Biotech Hunter | Biotech Hunter